Related Experiment Video
Updated: Jul 8, 2026
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome
Silvia Zaragoza Domingo1, Jordi Alonso2, Montse Ferrer2
1Neuropsychological Research Organization s.l. (Neuropsynchro), Barcelona, Spain.
Summary
Standardizing clinical outcome selection in neuroscience trials can improve success rates. This guidance offers a minimal step process for better evidence generation and regulatory acceptance, enhancing research efficiency.
Area of Science:
- Neuroscience
- Clinical Trials
- Psychiatry
- Neurology
Background:
- Clinical trials in neurosciences face high failure rates, particularly in psychiatry and neurology.
- A lack of standardized outcome selection processes hinders the identification of effective treatments.
- The Outcomes Research Group was established to promote best practices in outcome selection.
Purpose of the Study:
- To provide the first published guidance on standardizing clinical outcome selection in neuroscience.
- To define a minimal step process for evidence generation supporting outcome validity and patient-centricity.
- To offer considerations for regulatory acceptance in clinical trial design.
Main Methods:
- Development of a minimal step process for clinical outcome selection.
- Inclusion of key activities for evidence generation, focusing on content validity and patient-centricity.
- Incorporation of expert feedback on process risks and summarization of supporting examples.
Main Results:
- A standardized, minimal step process for clinical outcome selection in neuroscience is defined.
- The guidance addresses evidence generation, validity requirements, and regulatory considerations.
- Expert feedback highlights risks of process shortening and provides supporting examples.
Conclusions:
- The proposed methodology offers a consensus-based approach to clinical outcome selection for neuroscience research.
- Implementing these standard practices can enhance the efficiency and success likelihood of clinical trials.
- This guidance is available to researchers in industry, academia, and clinics to improve treatment identification.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...